Table 3.
Retinopathy− screening data from 3/2017–3/2021.
| Routine Eye Exams | Non-Routine Eye Exams | p Value | |
|---|---|---|---|
| Total (n = 216) | 87 (40.3%) | 129 (59.7%) | |
| Avg, Median Age (years) Range |
32.8, 31.0 18–65 |
33.6, 29.0 18–73 |
0.63 * |
| Female % | 58.6% | 55.0% | 0.68 † |
| SS (n = 180) | 68 (37.8%) | 112 (62.2%) | 0.098 † |
| SC (n = 36) | 19 (52.8%) | 17 (47.2%) |
Routine eye exams are defined as at least one screening DFE every 2 years. Non-routine eye exams are defined as patients with screening DFE only once during the study period or at least once but fewer than every 2 years during the study period. * p-value was obtained by two-tailed Welch’s t-test. The p-value from Mann–Whitney U test was 0.75. † p-value was obtained by Fisher’s exact test comparing sex/genotype distribution among patients with routine screening eye exams and patients with non-routine screening eye exams.